Audio Journal of Oncology Podcast

By Audio Medica News

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.


Category: Science

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast
    

Subscribers: 3
Reviews: 0
Episodes: 100

Description

As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoken comments on the clinical implications of cancer developments in the real-world context, as practiced by cancer doctors and clinicians around the globe. The AJO Podcast originates from the Audio Journal of Oncology staffed by ex-BBC professional journalists, and mentored by world-leading cancer practitioners from bodies including the American Society of Clinical Oncology, Cancer Research UK, Istituto Nazionale dei Tumori, and Action Radiotherapy. Each podcast is produced to the highest standards of audio recording and journalism and is subject to editorial appraisal to maintain that content, balance and clinical relevance of news and comment are delivered in a manner that's easy and enjoyable for listening while travelling, taking exercise, working or just relaxing. Please contact Audio Medica with your comments and make your contribution to supporting a vibrant community of clinical cancer communicators!

Episode Date
Topical BRAF-inhibiting Gel Controls Acneiform Rash in Patients with Colorectal Cancer Treated with EGFR-inhibition
May 02, 2025
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients with Newly Diagnosed Head and Neck Cancers
May 01, 2025
RAS Inhibitor Zoldonrasib Brings Clinical Benefit in Patients with G12D Mutated Non-Small Cell Advanced Lung Cancer
Apr 30, 2025
Exosome Liquid Biopsy for Earliest Pancreatic Cancer Detection
Apr 10, 2025
Long Remissions with Bispecific T-cell Engager Antibody Therapy for Patients with Relapsed Multiple Myeloma
Apr 09, 2025
Personalized Vaccine Brought Durable Immune Responses and Fewer Relapses in Head and Neck Cancers
Apr 09, 2025
Adding Anthracycline Improved Outcomes for Patients with High-Risk HR-positive, HER2-negative Breast Cancer
Mar 28, 2025
Specific Subgroups of Patients with Metastatic Castration Resistant Prostate Cancer Live Longer with Talazoparib Added to their Enzalutamide Therapy
Mar 13, 2025
Patients with Desmoplastic Melanoma Were Exceptional Responders to Single Agent Pembrolizumab
Mar 11, 2025
Bilateral Mastectomy and Salpingo-Oophorectomy Significantly Extend Survival In BRCA-mutation Carriers Who Already Have Breast Cancer
Feb 26, 2025
AUDIO JOURNAL OF ONCOLOGY: Randomized Study Found Surgery-Sparing Active Monitoring Safe in Patients With Low-risk DCIS
Jan 16, 2025
AUDIO JOURNAL OF ONCOLOGY: Safe to Spare Post-Mastectomy Chest Wall Radiotherapy in Most Patients with Intermediate Risk Breast Cancer
Jan 11, 2025
AUDIO JOURNAL OF ONCOLOGY: Increased Dietary Fiber Brings Longer Survival and Less GVHD After Allogeneic Stem Cell Transplantation
Jan 08, 2025
Adding a Bi-Specific T-Cell Engager Brings Striking Benefit in Childhood Acute Lymphoblastic Leukemia
Dec 17, 2024
Double-Edged CAR-T Therapy Improves Survival with Relapsed/Refractory Chronic Lymphoblastic Leukemia
Dec 09, 2024
Low Rates of Early Detection Drive Excess Breast Cancer Mortality in Underserved Communities
Apr 26, 2023
AUDIO JOURNAL OF ONCOLOGY—Options Identified for Chemotherapy Intensity Reduction in Acute Lymphoblastic Leukemia
Feb 13, 2023
AUDIO JOURNAL OF ONCOLOGY—Don’t Delay Stem Cell Transplant For Patients with Relapsed or Refractory Acute Myeloid Leukemia
Jan 23, 2023
AUDIO JOURNAL OF ONCOLOGY—Ibrutinib Enables Transplant-Free Therapy for Mantle Cell Lymphoma
Jan 20, 2023
AUDIO JOURNAL OF ONCOLOGY—Fast Durable Responses to Bi-Specific Antibody Therapy In Heavily Pre-Treated Multiple Myeloma
Jan 09, 2023
AUDIO JOURNAL OF ONCOLOGY—High Response Rates in Lung Cancer from Next Generation ROS1 Inhibitor 
Jan 06, 2023
AUDIO JOURNAL OF ONCOLOGY – ARROS-1 Study Finds ROS1 Tyrosine Kinase Inhibitor Has Promise as a Tumor Agnostic Therapy
Jan 05, 2023
AUDIO JOURNAL OF ONCOLOGY—Pan-AKT Inhibitor Tumor Agnostic Targeting  was Safe and Effective in Phase One Study
Jan 04, 2023
AUDIO JOURNAL OF ONCOLOGY—MYC-Targeted Drug Had Excellent Safety And Solid Tumor Responses
Dec 02, 2022
AUDIO JOURNAL OF ONCOLOGY—New Molecular Drug has Clinical Activity in Hepatocellular Carcinoma
Nov 11, 2022
AUDIO JOURNAL OF ONCOLOGY—Cell Therapy Markedly Improved Outcomes After Immunotherapy in Melanoma
Nov 08, 2022
AUDIO JOURNAL OF ONCOLOGY—Glioma in Adults: Next Generation Sequencing Validates BRAF Targeting
Nov 07, 2022
AUDIO JOURNAL OF ONCOLOGY—First Line Atezolizumab Extends Life in Unfit Patients with Lung Cancer
Oct 22, 2022
AUDIO JOURNAL OF ONCOLOGY—Breast Conservation: Machine-Learning Helps De-Escalate Breast Cancer Therapy
Oct 14, 2022
AUDIO JOURNAL OF ONCOLOGY—PARP-Inhibition Beyond Initial Therapy Extends Life with Advanced Ovarian Cancer
Oct 11, 2022
AUDIO JOURNAL OF ONCOLOGY – ”Progression to Acute Myeloid Leukemia Explained by Multi Omics Analysis
Oct 10, 2022
AUDIO JOURNAL OF ONCOLOGY—“PM 2.5” Evidence Links Particulate Air Pollution to Non-Small Cell Lung Cancer
Oct 03, 2022
CT Screening Cuts Lung Cancer Deaths 24-Per Cent Second Study Confirms
Feb 24, 2020
Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per Cent
Feb 07, 2020
New Front Line Standard for Older Patients with Chronic Lymphocytic Leukemia
Jan 24, 2020
Microbiome Diversity Key To Survival After Allogeneic Hematopoietic Cell Transplantation
Jan 14, 2020
Genomic-led AML Clinical Decision Making Within Seven Days
Dec 31, 2019
Ibrutinib: New Frontline Standard for Chronic Lymphocytic Leukemia?
Oct 07, 2019
Ibrutinib: New Frontline Standard for Chronic Lymphocytic Leukemia?
Oct 07, 2019
Head and Neck Cancer Therapy De-Escalation: A “Salutary Lesson”
Nov 12, 2018
Which New Combination for Metastatic Renal Cell Cancer?
Nov 12, 2018
Two Drug Combination Doubled Kidney Cancer Progression Free Survival
Nov 07, 2018
ALK—Targeted Lung Cancer Drugs Benefited Real World Patients 
Nov 07, 2018
First Line PARP Inhibition For Ovarian Cancer Assessed
Nov 02, 2018
BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib
Nov 01, 2018
PD-L1 Immunotherapy Delayed Triple Negative Breast Cancer Progression
Oct 31, 2018
Genomically Targeted Therapy Delays Advanced Breast Cancer Progression
Oct 31, 2018
Palbociclib Combination Prolongs Life After Breast Cancer Hormone Therapy
Oct 29, 2018
Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer
Oct 27, 2018
Pembrolizumab: No Survival Gains Second Line In Gastric Cancer
Oct 18, 2018